Tritanrix-HepB/Hib-MenAC
103812
Phase 3 mab completed
Quick answer
Tritanrix-HepB/Hib-MenAC for Whole Cell Pertussis is a Phase 3 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Whole Cell Pertussis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed